COVID-19
Gilead Sciences, which makes remdesivir, charges about US$2,340 per patient, and it agreed to send most of its remdesivir to the United States.  In July 2020, the Drug Controller General of India approved the third of three generic version of remdesivir made by Indian companies.  The cheapest of them costs 4800 rupees per vial, or US$64.31.